← SynDRA
APTO-253
SynDRA canonical compound SYN0039441 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | KLF4 |
|---|
| Mechanism of action | krüppel-like factor expression enhancer |
|---|
All known targets
Mechanisms of action (all sources)
- krüppel-like factor expression enhancer
Cross-references
Synonyms
- Lt-253
- LOR-253
- LOR-253(FORMER CODE)
- LT-253(FORMER CODE)
- Lt-253(former code)
- Lor-253(former code)
- WB59MRW00U
- LT-253
- RefChem:113566
- APTO-253 (hydrochloride)
- APTO253 free base
- UNII-WB59MRW00U
- APTO253
- LOR253
- orb1309990
- SCHEMBL10067266
- SCHEMBL29526147
- SCHEMBL29936273
- C22H14FN5
- EX-A3460
- LOR-253;LT-253
- HY-16291A
- MFCD25976826
- NSC789042
- s6963
- AKOS030526993
- CS-5226
- NSC-789042
- NCGC00484061-01
- NCGC00484061-02
- AC-36395
- BA166663
- DA-50656
- HY-16291
- MS-25879
- CS-0092600
- E76865
- T10352
- BRD-K68003372-001-01-6
Look up APTO-253 in the interactive SynDRA portal →